ALKS News and Press, Alkermes plc From 12/01/23

2023-12-01 10:17:15 ET The UBS pharma equity team is out with a quant list of most crowded stocks on the long and short side. Crowding is a sentiment metric that basically measure popularity in positioning (long or short). It indicates if a stock has a significantly above-average number...

NORTHAMPTON, MA / ACCESSWIRE / November 29, 2023 / Alkermes Originally published in Alkermes September 2023 Corporate Responsibility Report We understand the significant potential impacts that pharmaceuticals can have on the environment. We maintain strict internal protocols to adhere to the...

2023-11-28 11:56:40 ET More on SPDR S&P 500 ETF Trust: 2024 Analyst Outlook: Mott Capital On Market Volatility, The Fed, And Investor Challenges And Opportunities The Week On Wall Street: Holiday Edition Broad Turn In Weekly Momentum Bodes Well For Stocks ...

2023-11-25 16:32:53 ET More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc. Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript Immunocore: First Half Of 2024 IMC-F106...

NORTHAMPTON, MA / ACCESSWIRE / November 21, 2023 / Alkermes Originally published in Alkermes September 2023 Corporate Responsibility Report We strive to conduct our business activities in a manner that minimizes the environmental impacts of our operations and promotes effective stewardship o...

2023-11-20 22:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

NORTHAMPTON, MA / ACCESSWIRE / November 20, 2023 / Alkermes This month we recognize Movember, a time for us to shine a light on issues affecting men's health. Excessive drinking may affect men's mental, sexual and physical health. Alkermes is committed to supporting men living with alcoholuse d...

2023-11-20 11:49:37 ET Summary Intra-Cellular Therapies, Inc. is a mid-cap biopharmaceutical company focused on developing treatments for neuropsychiatric and neurological disorders. The company's commercial asset, Caplyta, has achieved significant sales growth and is an exciting ...

2023-11-17 08:16:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mural Oncology (NASDAQ: MURA ) stock is rising higher on Friday after the company was separated from Alkermes (NASDAQ: ALKS ). This separation went into ...

2023-11-17 07:33:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! Moving stocks this morning are a business separation, earnin...